Browsing Tag
United Kingdom
962 posts
Brent Council partners with Infosys to enhance employability through digital skills
In a significant partnership aimed at addressing the digital skills gap in the UK, Infosys has teamed up…
October 19, 2021
TechnipFMC wraps up takeover of pipe technology firm Magma Global
TechnipFMC has wrapped up the previously announced deal to take full ownership of Magma Global, a UK-based provider…
October 14, 2021
Glenmark gets marketing approval for Ryaltris in 13 European countries
Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13…
September 30, 2021
Rolls-Royce to sell ITP Aero to Bain Capital-led consortium for €1.7bn
British engineering company Rolls-Royce has agreed to divest ITP Aero, a Spanish aero engine and gas turbine manufacturer,…
September 29, 2021
TCS develops Into Work Cardiff mobile app for Cardiff Council
Tata Consultancy Services (TCS) said that it has designed and developed a new mobile app called Into Work…
September 28, 2021
AstraZeneca and Imperial spin-off VaxEquity enter into saRNA partnership
AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and…
September 26, 2021
French drinks giant Pernod Ricard to acquire The Whisky Exchange
French alcoholic drinks producer Pernod Ricard has agreed to acquire The Whisky Exchange, a UK-based spirits online and…
September 23, 2021
HCL Technologies to help Finastra drive digital transformation in South Korea and Taiwan
HCL Technologies said that it has expanded its partnership with Finastra, a pure-play software vendor for the financial…
September 20, 2021
AstraZeneca reports positive results for phase 2 COAST trial of oleclumab and monalizumab
AstraZeneca has reported positive results from the COAST phase 2 trial of its oleclumab or monalizumab in combination…
September 18, 2021
DESTINY-Gastric02 phase 2 trial results : Enhertu shows clinically meaningful and durable tumor response
AstraZeneca said that Enhertu (trastuzumab deruxtecan) has shown clinically meaningful and durable response in the DESTINY-Gastric02 phase 2…
September 18, 2021